News
Dr. Hiroaki Suga Receives The Ojima Distinguished Lectureship Award in Chemistry
Dr. Hiroaki Suga gave a lecture at The Ojima Distinguished Lectureship Award in Chemistry on April 26 at the Wang Center, SBU. (Read more)
ICB&DD Welcomes New Members: Drs. Anissa Abi-Dargham, Stuti Sharma and Markus Riessland
Dr. Anissa Abi-Dargham, Distinguished Professor and The Lourie Endowed Chair, Department of Psychiatry and Behavioral Health, Stony Brook Renaissance School of Medicine
Dr. Stuti Sharma, Assistant Professor, Department of Biochemistry and Cell Biology, Stony Brook Renaissance School of Medicine
Dr. Markus Riessland , Assistant Professor, Department of Neurobiology and Behavior, Stony Brook Renaissance School of Medicine
ICB&DD 17th Annual Symposium "Frontiers in Chemical Biology and Drug Discovery" at the SAC (read more)
From SBU news Drug Discoveries, Students Research Showcased at ICB&DD Symposium
ICB&DD welcomes New Members: Drs. Matthew Parker and Jeffrey Lipshultz
Dr. Matthew Parker, Assistant Professor, Department of Psychiatry and Behavioral Health. Stony Brook Renaissance School of Medicine
Dr. Jeffrey Lipshultz, Assistant Professor, Department of Chemistry.
(read more)
Congratulations to ICB&DD Member,Dr. Jingfang Ju, Professor in the Department of Pathology for being on the cover of the International
Journal of Oncology (Int. J. Oncol.) for the month of July 2023. Int. J. Oncol. is an international journal devoted to oncology research and cancer treatment.
(See more)
Dr. John Hartwig Receives The Ojima Distinguished Lectureship Award in Chemistry
Dr. John Hartwig gave a lecture at the Ojima Distinguished Lectureship Award in Chemistry on May 5 at the Wang Center, SBU.
TVM Capital Life Science (TVM) is committing up to $24 million for a development program to advance NE-DHA-SBT-1214, Dr. Iwao Ojima's compound, to market for the treatatment of colorectal cancer and other solid tumors. (read more one) (read more two)
Message from the Director
Dr. Iwao Ojima, Distinguished Professor and Director, ICB&DD
Welcome to the Institute of Chemical Biology & Drug Discovery
The primary objective of ICB&DD is to establish a world-class “Center of Excellence” in chemical biology and drug discovery at Stony Brook. The rapid and impressive advancement of chemical biology in the last decades clearly demonstrated that solutions for vast majority of medical problems rely on the understanding of the molecular basis of diseases, therapeutic targets, drug actions, and drug resistance. ICB&DD promotes highly productive interdisciplinary and multidisciplinary research bridging the West, East and South campuses as well as Brookhaven National Laboratory to attack major and significant biomedical problems to find solutions including the discovery of novel therapeutic drugs. ICB&DD significantly contributes to the advancement of a truly comprehensive biomedical research enterprise from molecular science to clinic at Stony Brook.
ICB&DD Events
ICB&DD 2023 SYMPOSIUM Poster Session
|